From blockbusters to biosimilars – the Patent Perspective Dr. Thomas Friede Partner Patentanwalt & European Patent Attorney 2nd C5 Forum Biosimilars 2012.
From blockbusters to biosimilars – the Patent Perspective
Challenges and its Resolution in Biosimilar Clinical Development Chirag Shah Ph.D,PGDPM Asso.Director & Head-Clinical Trials Cliantha Research Ltd 27 Oct.
